Antimicrobial susceptibilities of Campylobacter fetus: report from a reference laboratory

Ming May Zhang1, Tanner A Melton1, Haris Akhtar2

  • 1Department of Pharmacy Services, Mayo Clinic, Rochester, Minnesota, USA.

PubMed

Insights

Campylobacter fetus infections are a concern for vulnerable populations. Gentamicin and meropenem show promising antimicrobial susceptibility, while ciprofloxacin results vary, highlighting the need for interpretive criteria.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Clinical Pharmacy

Background:

  • Campylobacter fetus causes disease, especially in elderly and immunocompromised individuals.
  • Limited data exist on antimicrobial susceptibility patterns and interpretive criteria for C. fetus.
  • This study addresses the need for more information on C. fetus antimicrobial resistance.

Approach:

  • Reviewed antimicrobial susceptibilities of 105 unique C. fetus isolates over 11 years.
  • Utilized agar dilution method for ciprofloxacin, doxycycline, erythromycin, gentamicin, meropenem, and tetracycline.
  • Analyzed minimal inhibitory concentration (MIC) distributions, MIC50, and MIC90.

Key Points:

  • Blood cultures were the most common source of C. fetus isolates.
  • Gentamicin and meropenem exhibited favorable MIC50 and MIC90 values (1 µg/mL).
  • Ciprofloxacin showed variable results (MIC50=1 µg/mL, MIC90=>2 µg/mL), and erythromycin had MIC50/MIC90 of 2 µg/mL.

Conclusions:

  • Gentamicin and meropenem are potential therapeutic options for severe C. fetus infections.
  • Ciprofloxacin may be suitable only after susceptibility testing due to variable results.
  • Development of C. fetus interpretive criteria is crucial for guiding empiric and definitive therapies.

Related Concept Videos

Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...